Melanophore-stimulating hormone (MSH) release from the pars intermedia of the pituitary gland is probably regulated by multiple factors of hypothalamic origin. We have examined a number of potential reguiatory factors for their effects on MSH release from the amphibian Xenopus /a&s. Serotonin and acetylcholine have no effect on MSH release. Both adrenaline and noradrenaline inhibit release of MSH in a dose-dependent manner. Studies with specific receptor agonists and antagonists reveal that these neurotransmitters exert their in vitro effects primarily through a dopamine D-2 receptor, although an ol-adrenergic receptor could not be excluded. We further conclude that the pars intermedia of X. laevis lacks a O-adrenergic receptor for the regulation of MSH secretion from the pars intermedia. In mammals, this receptor activates the adenylate cyclase system. Our studies reveal that despite the lack of O-adrenergic receptors, cyclic-AMP is likely an intracellular factor involved in the stimulation of MSH release. 0 1986 Academic PESS, IIIC.
Melanophore-stimulating hormone (MSH), released from the pars intermedia of the pituitary gland, controls pigment dispersion in dermal melanophores during background adaptation of amphibians. The release of this hormone is regulated by factors of hypothalamic origin which are thought to be released from nerves terminating in the neurointermediate lobe. Hypothalamic regulation is believed to be mainly inhibitory. Dopamine is thought to be a very important neurotransmitter in this regard (Davis and Hadley, 1978; Jenks, 1977; Terlou et al., 1974) , and in at least one amphibian species (Verburg-van Kemenade et aE., 1986 ) the neurotransmitter GABA is likely involved. Other classical neurotransmitters have also been implicated in the regulation of melanotropin release. The ind&amine serotonin has been reported to stimulate release from melanotropes of lower vertebrates (Thornton and Geschwind, 1975 ) and a cholinergic mechanism has been suggested for stimulation of the pars intermedia of an hmphibian species (Hadley et al., 1976; Dierst-Davis et al., 1966) . In mammals, a P-adrenergic met nism for stimulation of melanotropin secretion is well established (Cote et al., 1980; Tilders et al., 1981) . Stimulation of this preceptor activates the adenylate cyclase system, thus increasing intracellular levels of cyclic-AMP (cAMP), which leads to elevated release of MSH (Cote et al., 1980; . For amphibians, the initial indication of P-adrenergic stimulation of MSH secretion from Rnna pipiens: (Bower et al., 1974) has recently been extended to a second amphibian species, Rana ridibunda (Tonon et al., 1983) . XII the aquatic toad Xenopus laevis, the p-adren ergic receptor' agonist isopro'terenol has been reported to inhibit the release of &WI and other peptides derived from the common prohormone pro-o,piomelanoj cortin (Loh and Gainer, 1977) . This observation appears to be in agreement with a report that CAMP inhibits M!SH release in this species , although it has earlier been reported'that cGMP is exl tremely potent in stimulating release of MSH from Xenopus neurointermediate lobes (Jenks, 1977) . In addition to the B-adrenergic receptor, the presence of a-adrenergic receptors on melanotropes of both an amphibian (Bower et al., 1974 ) and a mammalian species (Jackson and Lowry, 1983) has been proposed. In both cases this receptor is reported to be involved in inhibition of MSH release. We have undertaken a study to evaluate the possible involvement of various neurotransmitters in the control of MSH release from the pars intermedia of X. laevis. This study was accomplished through the analysis of release of immunoreactive melanotropin from superfused neurointermediate lobes. By using specific receptor agonists and antagonists, an attempt was made to characterize the receptor mechanisms involved. As the physiological state of the animal (i.e., white-or black-background-adapted) may have some influence on melanotrope sensitivity to secretagogues, we tested each potential secretagogue on neurointermediate lobes of both white-and black-background-adapted animals.
MATERIALS AND METHODS
Animals. X. laevis were bred and reared in our acquatic facility. Animals were adapted to black or white background in black or white containers under constant illumination at 22". Degree of pigment dispersion in dermal melanophores was determined by measurement of the melanophore index according to Hogben and Slome (1931) .
In vitro superfusion experiments. Details concerning our method of superfusion of neurointermediate lobes are given elsewhere (Verburg-van Kemenade et al., 1986) . Briefly, super-fusion was performed using small perifusion chambers (10 pl), each containing an individual lobe. The incubation medium contained 112 mM NaCl, 2 mM KCl, 2 rn44 CaCl,, 15 mM Hepes, pH 7.38, 0.3 mgiml BSA, 2 mg/ml glucose. Medium was pumped through each chamber (1.5 ml/hr) and fractions of 7.5 min were collected. Fractions were stored frozen (-20") before submitting them to radioimmunoassay for MSH determinations. As described earlier (Verburg-van Kemenade et a/., 1986) , within an experiment the results of those lobes showing similar baseline patterns of release were grouped, percentage basal release was calculated for each lobe within the group, and these values were then averaged. Neurotransmitters, or their specific agonists or antagonists, were administered at various time periods during the superfusion. The following products were tested either individually or in various combinations: the neurotransmitters serotonin, acetylcholine, adrenaline, and noradrenaline; the cu-adrenergic receptor agonist phenylephrine and its antagonist phentolamine; the B-adrenergic receptor agonist isoproterenol and its antagonist propranolol; and the dopamine D-2 receptor antagonist sulpiride (all purchased from Sigma). Several experiments were conducted using the cyclic-AMP analog g-bromo-adenosine 3',5'-monophosphate (8-Br-CAMP, Sigma).
Radioimmunoassay. The MSH concentration in the effluent was quantified by radioimmunoassay, using an antiserum produced and characterized by Vaudry et al. (1978) . It shows equal cross-reactivity to desacetyl-cY-MSH and a-MSH. Immunobound and unbound radioactive MSH were separated by precipitation with polyethylene glycol. Synthetic a-MSH (Sigma) was used as a standard. All samples were measured in duplicate.
RESULTS
Effects of serotonin and acetylcholine.
Serotonin in concentrations
ranging from 10Vg to lop5 M was unable to alter basal MSH secretion in lobes from black-or white-adapted animals. Figure lb shows the results-from superfusion experiments whereby 10P8, 10e6, and lop5 M of serotonin were tested. Similarly, basal secretion was unaffected by acetylcholine in concentrations ranging from 10eg to 10P5 M (Fig. la) .
Involvement of wadrenergic and p-adrenergic receptor mechanisms. The two neurotransmitters adrenaline and noradrenaline exhibited a dose-dependent inhibitory effect on secretion of immunoassayable c+MSH ( Fig. 2a and Table 1 ). Effective concentrations ranged from 10e7 to 10m5 M (Table 1 ). The lobes were slightly more sensitive to adrenaline than to noradrenaline. The inhibition of MSH secretion induced by adrenaline or by noradrenaline, both applied at a concentration of 10P6 M, was not affected by the ol-adrenergic receptor antagonist phentolamine ( and d) nor by the P-adrenergic receptor antagonist propranolol (Fig. 2b) . Both antagonists were tested in concentrations of up to 10V4 M. When adrenaline was, however, used in concentrations of lo-' M, we observed a partial blockage of the inhibition by phentolamine (Table 2 ). The inhibitory effect on secretion induced by 10V6 M adrenaline or 10m6 M noradrenaline could be blocked by the dopamine D-2 receptor antagonist sulpiride (Figs. 2e and f). The (Yadrene,rgic agonist phenylephrine inhibited secretion 'when used at high concentrations of 10V5 M (Table I ). The, inhibition of MSH secretion induced by 2 x 10e5 M of phenylephrinel was to a great extent antagonized by the administration of 10d4 M of phentolamine (Fig. 3) .
In neurointermediate lobes of blackadapted animals, the P-adrenergic receptor agonist isoproterenol appeared to be unable to alter the basal level of MSH secretion when added in low concentrations of 10-10-10-7 M. At high concentrations (1O-5 M), the effect of isoproterenol on MSH secretion is clearly inhibitory (Fig.  4a ). This inhibitory effect on melanotr secretion could not be blocked with propranolol (Fig. 4~) . Both sulpiride and phentolamine were, however, able to block the isoproterenol-induced inhibition (Fig. 4d  and Table 2 ). An experiment with isoproterenol, but with lobes from white-adapted animals, did not show any stimulatory effect for this substance (Fig. 4b) . Moreover, in an experiment with lobes from blackadapted animals that were maintained continuously under submaximum, inhibition by dopamine ( 10e6 M), isoproterenol again failed to induce stimulation of release. Also, we could not demonstrate any stimulation with isoproterenol in experiments that were conducted with the incubdtion medium at pH 6.8. Hadley et al. (1976) have reported that in Rana, lowering the pH of the incubation medium reduced basal levels of melanotropin secretion, thus increasing sensitivity in detecting stimuiatory effects on secretion. In Xenopus we foun no reduction in basal secretion after lowering the pH from 7.38 to 6.80.
Effects ofcyclic-AMP.
Lobes originating from animals adapted to a black background appeared to be insensitive to 8-Rcyclic-AMP (Fig. 5a ). Additional experiments, where 8-Br-cyclic-AMP was given for SO-min periods, also showed no effect of this substance on MSH release. In comparison to lobe,s from black-adapted animals, lobes from white-adapted animals showed 'considerably more variation in their baseline pattern of MSH release, which generally tended to decl more rapidly. FIG. 2. Effects of noradrenaline, adrenaline, and receptor antagonists (propranolol, S-adrenergic receptor antagonist; phentolamine, ol-adrenergic receptor antagonist; sulpiride, dopamine D-2 receptor antagonist) on MSH secretion from superfused nemointermediate lobes of black-backgroundadapted Xenopus laevis. In each experiment noradrenaline or adrenaline was given during three 15 min periods; administration of the receptor antagonist was started several fractions before the second pulse of noradrenaline or adrenaline and continued for several fractions after this pulse, as indicated in the figure. All graphs represent the mean of two to four experiments and the bars represent -SEM. Note. Secretagogues were added during 15min periods to superfused lobes; 7.5min fractions were collected and the amount of MSH in each fraction determined with a radioimmunoassay. Average value of MSH in ihe three fractions before addition of secretagogue was defined as basal level and the decrease in MSH value observed for the second 7.5-min fraction of secretagogue addition was expressed as a percentage of the basal value. Percentage inhibition is given + SEM and the numbers in parentheses indicate the number of independent determinations for each concentration of secretagogue tested.
that biosynthesis and release of pro-opiomelanocortin-related peptides are essentially normal, and that the ultrastructure of the tissue compared favorably to freshly dissected tissue (unpublished results).
Biochemical (Loh and Gainer, 1977; Martens et al., 1982) and morphological studies Weatherhead and Whur, 1972) have shown that the cells of the pars intermedia of black-background-adapted toads are extremely active in biosynthesis and release of melanotropins. In contrast, white-backgroundadapted animals have low biosynthetic rates in these cells and, in V~'VO, release of melanotropins is under tonic inhibition.
During in vitro superfusion, neurointermediate lobes from blackbackground-adapted animals gave relatively stable baselines of MSR release, while lobes from white-backgroundadapted animals tended to give declining 
Note. Each secretagogue was administered during a 15min period to superfused lobes and the percentage inhibition of MSH secretion determined as described in Table 1 . Administration of receptor antagonists (receptor specificity indicated in parentheses) was started several fractions before a second 15-min pulse of secretagogue and continued for several fractions after this pulse. inhibition of reIease by the secretagogue during this second pulse was compared to that obtained during the first pulse. Symbols: (+) complete or almost complete antagonism of inhibitory effect of secretagogue; (2) partial antagonism of inhibitory effect of secretagogue; (-) no detectable antagonism of secretagogue; n.d., not determined. Phenylephrine (2 x 10e5 M) was added during two 15min periods; phentolamine administration was started several fractions before the second pulse of phenylephrine and continued for several fractions after this pulse, as indicated in the figure. baselines. In our opinion this latter observation is indicative of hormone depletion and reflects the low biosynthetic capacity of the melanotropes of white-adapted animals. In lobes of black-adapted animals the high level of hormone production can apparently maintain a high rate of in vitro release.
The results of our super-fusion experiments clearly show that the indolamine serotonin has no effect on the rate of MSH release from the pars intermedia of either white-or black-background adapted Xenopus. Immunocytochemically, we have found that in X. laevis, serotonergic fibers are restricted to the neural lobe, and no evidence for the presence of serotonin in the pars intermedia was found (unpublished results). Thus it would seem unlikely that serotonin plays a direct role in the regulation of peptide release from the pars intermedia of Xenopus. In this respect, there could be species differences in the regulation of melanotropin release. Thornton and Geschwind (1975) found a dose-dependent potent stimulation of MSH release in the lizard Anolis carolensis. Ueda et al. (1984) and Kondo et al. (1983) demonstrated the presence of serotonergic fibers in the pars intermedia of Rana catesbeiana. That serotonergic innervation of the pars intermedia might be restricted to lower vertebrate species is suggested by the studies of Kondo and coworkers, who showed that the pars intermedia of the rat, hamster, and dog were serotonin negative.
Electron microscopic studies have indicated the existence of cholinergic axon vesicles in the pars intermedia of Rana (Nakai and Gorbman, 1969) and the neurotransmitter acetylcholine has been shown to stimulate MSH secretion (Davis and Hadley, 1978) . Hopkins (1971) , in characterizing neurons of the pars intermedia of X. laevi , concluded that cholinergic innervation i il absent from the intermediate lobe of this species. The results of our superfusion studies, showing .that acetylcholine has no influence on MSH secretion, are in agreement with Hopkins' conclusion that acetylcholine has no role, at the level of the Xenopus pars intermedia, in regulating melanotropin release.
The observation that both adrenaline and noradrenaline were very effective in inducing inhibition of MSH release in a dosedependent manner suggests the involvement of an a-adrenergic receptor mechanism. This suggestion is supported by the fact that the cw-adrenergic receptor agonist phenylephrine inhibited hormone release, a response that could be antagonized by phentolamine.
However, high concentrations of phenylephrine were needed and in antagonizing the adrenaline-and noradrenaline-induced inhibition of secretion, the dopamine D-2 receptor antagonist sulpiride proved to be much more potent than the (Yadrenergic receptor antagonist phentolamine. This indicates that, in vitro' at least, adrenaline and noradrenaline inhibit MSH release primarily through a dopamine re- Administration of the receptor antagonist was started several fractions before the second pulse of isoproterenol and continued for several fractions after this pulse. All graphs represent the mean of at least two individual experiments and bars represent -SEM. Basal levels of release for individual lobes within each experiment were isoproterenol black, 2608 and 2312 pg MSH/fraction; isoproterenol white, 1424 and 948 pg MSH/fraction; isoproterenolipropranolol, 2408and 872 pg MSHifraction; isoproterenolisulpiride, 1600. 1128, 1868, and 1336 pg MSH/fraction. ceptor mechanism, similar to the situation reported for the rat pars intermedia . In in vitro experiments the tissue is, of necessity, flooded with potential secretagogue.
In this situation adrenaline or noradrenaline can inhibit MSH release through activation of either abundantly available dopamine-type receptors (a manuscript concerning their characteristics is in preparation), or less abundant a-adrenergic receptors. If in viva, however, the neurotransmitter was to be delivered to the tissue in highly directed synapses between adrenergic nerve terminals and the melanotropes; then it cannot be excluded that an a-adrenergic receptor mechanism plays a role in regulating the pars intermedia function. With respect to possible P-adrenergic receptor mechanisms, we have shown that for Xenopus, low concentrations of the l3-adrenergic receptor agonist isoproterenol have no effect on MSH release and that high concentrations actually inhibit release, The fact that this inhibition could not be blocked by, the P-receptor antagonist pro* pranolol, but was blocked by sulpiride or phentolamine,
indicates that it does not involve activation of a P-adrenergic receptor; and we therefore conclude that Xenapus KEMENADE, JENKS , AND VAN OVERBEEKE are not regulated through a P-adrenergic mechanism. In contrast, it has been demonstrated for both R. pipiens (Bower et al., 1974) and R. ridibunda (Tonon et al., 1983 ) that a P-receptor mechanism stimulates release of MSH from the pars intermedia.
It is interesting to note that with respect to the P-adrenergic receptor, a similar discrepancy between the frog and Xenopus has been reported for the receptor profile of their erythrocytes. Frog erythrocytes contain a high number of p-adrenergic receptors, whereas the erythrocytes of Xenopus lack this type of receptor (Cerione et al., 1983) . P-adrenergic receptors generally activate the adenylate cyclase system (Cote et al., 1980; . The lack of this receptor on MSH cells of X. laevis raises questions concerning the involvement of cyclic-AMP as an intracellular factor for stimulation of hormone release. In both our present experiments and those reported earlier , we found a clear stimulation of MSH release, in contrast to who conclude from their results that cyclic-AMP inhibits release of MSH. In the present investigation the superfusion system has allowed us to follow the time course of cyclic-AMP-induced stimulation. These studies have revealed that a pulse of S-Brcyclic-AMP is so effective in stimulating the secretory process, that in many cases the lobes became almost depleted of MSH and thus could no longer maintain release and were hardly sensitive to subsequent
